http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3658186-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d50a5d08fff80f620aa6f328cd9bc85e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68f3e4eebe135a680af0df762ccbc79a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff87ba78e19692efa1ed6e441d6867d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f097e80ba62f21fff37d197361ad8572
publicationDate 2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3658186-A1
titleOfInvention Phosphatidylserine targeting fusion molecules and methods for their use
abstract The invention relates to fusion molecules of a cytokine or a portion thereof and a polypeptide that targets the phosphatidylserine fusion protein, pharmaceutical compositions thereof, and methods for their use in targeting. of a cytokine or part thereof to a pathological site and the treatment of a disease or condition susceptible to treatment by cytokines.
priorityDate 2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16069147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5365800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175988

Total number of triples: 53.